EUTOS Score Is Not Predictive for Survival and Outcome in Patients (pts) with Chronic Myeloid Leukemia in Early Chronic Phase (CML-CP) Treated with Tyrosine Kinase Inhibitors (TKIs) At MD Anderson Cancer Center (MDACC)

被引：0
|
作者：
Nazha, Aziz [1 ]
Jabbour, Elias [1 ]
Cortes, Jorge E. [1 ]
O'Brien, Susan [1 ]
Shan, Jenny [1 ]
Garcia-Manero, Guillermo [1 ]
Quintas-Cardama, Alfonso [1 ]
Kantarjian, Hagop M. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1609 / 1609
页数：1
相关论文
共 50 条
  • [31] Bosutinib is safe and active in patients (pts) with chronic phase (CP) chronic myeloid leukemia (CML) with resistance or intolerance to imatinib and other tyrosine kinase inhibitors
    Bruemmendorf, T. H.
    Cervantes, F.
    Kim, D.
    Chandy, M.
    Fischer, T.
    Hochhaus, A.
    Liu, D.
    Ossenkoppele, G. J.
    Hewes, B.
    Cortes, J. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] Long term follow-up of frontline dasatinib in patients (pts) with early chronic phase chronic myeloid leukemia (CML-CP).
    Maiti, Abhishek
    Kantarjian, Hagop M.
    Patel, Keyur
    Borthakur, Gautam
    Ravandi, Farhad
    Verstovsek, Srdan
    Ferrajoli, Alessandra
    Estrov, Zeev
    Kadia, Tapan M.
    Skinner, Jeffrey A.
    Poku, Rebecca A.
    Dellasala, Sara
    Luthra, Rajyalakshmi
    Jabbour, Elias
    Cortes, Jorge E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [33] EUROPEAN TREATMENT AND OUTCOME STUDY (EUTOS) SCORE PREDICTS EARLY MOLECULAR RESPONSE TO IMATINIB THERAPY IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS (CP-CML)
    Reddy, K. Sudheer
    Manickavasagam, M.
    Sampath, V. Venkata
    Barghavi, D.
    Vindhyavasini, A.
    Pai, A.
    Balambika, R. G.
    ANNALS OF ONCOLOGY, 2014, 25
  • [34] Resistance, Outcome and the Development of Mutations with Dasatinib in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP).
    Shah, Neil
    Bahceci, Erkut
    Lambert, Alexandre
    Ploughman, Lynn
    Radich, Jerald
    BLOOD, 2009, 114 (22) : 460 - 460
  • [35] Outcome of Patients (pts) with Chronic Myeloid Leukemia (CML) Treated with Tyrosine Kinase Inhibitors (TKI) Who Have a History of Prior Malignancies
    Koller, Paul B.
    Kantarjian, Hagop M.
    Koller, Charles
    Jabbour, Elias
    O'Brien, Susan
    Verstovsek, Srdan
    Borthakur, Gautam
    Estrov, Zeev
    Quintas-Cardama, Alfonso
    Cortes, Jorge E.
    BLOOD, 2011, 118 (21) : 1618 - 1618
  • [36] Early molecular response in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with dasatinib (DAS) or imatinib (IM) from DASISION.
    Shah, Neil P.
    Saglio, Giuseppe
    Hochhaus, Andreas
    Bilmes, Robyn
    Li, Li
    Cortes, Jorge E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] Outcome of Patients (pts) with Chronic Myeloid Leukemia (CML) After Failure to 2nd and 3rd Tyrosine Kinase Inhibitors (TKIs).
    Li, Liunan
    Kantarjian, Hagop
    Zhao, Meng
    O'Brien, Susan
    Jabbour, Elias
    Quintas-Cardama, Alfonso
    Burton, Elizabeth
    Faderl, Stefan
    Ferrajoli, Alessandra
    Cortes, Jorge E.
    BLOOD, 2010, 116 (21) : 529 - 530
  • [38] Detection of new mutations in patients (pts) with imatinib-resistant chronic myeloid leukemia in chronic phase (CML-CP) treated with nilotinib.
    Hochhaus, A.
    Saglio, A.
    Kantarjian, H.
    Haque, A.
    Shou, Y.
    Woodman, R. C.
    Hughes, T. P.
    Radich, J. P.
    Martinelli, G.
    Kim, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] Tolerability of Asciminib vs Investigator-Selected (IS) Tyrosine Kinase Inhibitors (TKIs) in the Phase 3 ASC4FIRST Study in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
    Issa, Ghayas C.
    Larson, Richard A.
    Hughes, Timothy P.
    Hochhaus, Andreas
    Takahashi, Naoto
    Bombaci, Felice
    Wang, Jianxiang
    Kim, Dong-Wook
    Dong, Dennis
    Kim, Hwan
    Gu, Ennan
    Zhang, Yifan
    Kapoor, Shruti
    Agrawal, Nithya
    Jinwal, Rajendra
    Damon, Andrea
    Sadek, Islam
    Cortes, Jorge E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S368 - S368
  • [40] Gimema Registry of Conception/Pregnancy in Adult Patients Diagnosed with Chronic Myeloid Leukemia (CML) Treated with Tyrosine Kinase Inhibitors (TKIs)
    Abruzzese, Elisabetta
    Scortechini, Anna Rita
    Gugliotta, Gabriele
    Pierri, Ivana
    Musolino, Caterina
    Iurlo, Alessandra
    Mastrullo, Lucia
    Caracciolo, Clementina
    Orlandi, Ester
    Galimberti, Sara
    Salvucci, Marzia
    Avanzini, Paolo
    Sica, Simona
    Alimena, Giuliana
    Bocchia, Monica
    Pregno, Patrizia
    D'Emilio, Anna
    Gambacorti-Passerini, Carlo
    Stagno, Fabio
    Santorsola, Domenico
    Castagnetti, Fausto
    Perrotti, Alessio Pio
    de Fabritiis, Paolo
    Baccarani, Michele
    BLOOD, 2014, 124 (21)
12345